Skip to content

Schrodinger SDGR Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
PDF Solutions logo
PDF SolutionsPDFS

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-19.7%
Enterprise value$984.71M-18.3%
P/S4.5×-1.7×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's capital investments accrued but not yet paid?
Schrodinger (SDGR) reported capital investments accrued but not yet paid of $78K in Q1 2026.
How has Schrodinger's capital investments accrued but not yet paid changed year-over-year?
Schrodinger's capital investments accrued but not yet paid increased by 500.0% year-over-year, from $13K to $78K.